ACUTA CAPITAL PARTNERS, LLC — 13F Holdings & Portfolio

CIK 1582844 · latest 13F-HR filed 2026-08-14

ACUTA CAPITAL PARTNERS, LLC manages $143.5M in 13F-reported U.S. long-equity assets across 23 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are PRAX (19.32%), WHWK (14.96%), TNGX (8.52%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 5 new positions and exited 8; 10 existing positions rose in reported value and 6 fell.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM
$143.5M

Long-equity book

Holdings
23

Distinct positions

Period
2026-06-30

Filed 2026-08-14

Q/Q Activity
+5 / −8 / ↑10 / ↓6

vs 2026-03-31

Portfolio charts

Latest quarter's book, what changed, and how the portfolio has evolved across filings.

Portfolio map

Q2 26

Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.

Sector mix

% of 13F value

Sectors from each company's SIC code; funds and ETFs grouped separately.

Biggest buys and sells

Q1 26 → Q2 26

Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.

13F assets and positions

4 quarters

Total reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.

Top positions over time

reported value

The eight largest current positions, valued at each quarter end.

Concentration

top 10 = 73.7%

Cumulative share of the portfolio held in the largest N positions.

Firm Profile & Key People

As of the firm’s regulatory filing dated Jun 30, 2026.

Assets Under Management
$172.5M
Discretionary
$172.5M
Employees
4
Accounts
3
Address
255 SHORELINE DRIVE
SUITE 515
REDWOOD CITY, CA 94065
Phone
(650) 486-0508
Name Title / Status Ownership Type
DALAL, ANUPAM, AKSHAY ControlMANAGING MEMBER, CHIEF INVESTMENT OFFICER
since Dec 2017
75% or moreIndividual
DALAL, ANUPAM, AKSHAY ControlMANAGING MEMBER, CHIEF INVESTMENT OFFICER
since Dec 2017
75% or moreIndividual
SMITH, SCOTT, RANDALL ControlCHIEF OPERATING OFFICER, CHIEF COMPLIANCE OFFICER
since Aug 2020
Less than 5%Individual
SMITH, SCOTT, RANDALL ControlCHIEF OPERATING OFFICER, CHIEF COMPLIANCE OFFICER
since Aug 2020
Less than 5%Individual
THE LIN-LAY FAMILY 2007 TRUST DATED SEPTEMBER 7, 2007MEMBER
since Aug 2018
10–25%Domestic Entity
THE LIN-LAY FAMILY 2007 TRUST DATED SEPTEMBER 7, 2007MEMBER
since Aug 2018
10–25%Domestic Entity
LAY, GRACE, VIVIAN Control
Indirect owner via THE LIN-LAY FAMILY 2007 TRUST DATED SEPTEMBER 7, 2007
BENEFICIARY/TRUSTEE
since Aug 2018
General partner, trustee or managerIndividual
LAY, GRACE, VIVIAN Control
Indirect owner via THE LIN-LAY FAMILY 2007 TRUST DATED SEPTEMBER 7, 2007
BENEFICIARY/TRUSTEE
since Aug 2018
General partner, trustee or managerIndividual
YU, MANFRED, HSIAO-WEI Control
Indirect owner via THE LIN-LAY FAMILY 2007 TRUST DATED SEPTEMBER 7, 2007
TRUSTEE
since Aug 2018
General partner, trustee or managerIndividual
YU, MANFRED, HSIAO-WEI Control
Indirect owner via THE LIN-LAY FAMILY 2007 TRUST DATED SEPTEMBER 7, 2007
TRUSTEE
since Aug 2018
General partner, trustee or managerIndividual
Ownership & leadership changes · 6 filings with changes since Apr 1, 2015

From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.

Mar 31, 2022 filing
  • ChangedLAY, GRACE, VIVIAN · indirect via THE LIN-LAY FAMILY 2007 TRUST DATED SEPTEMBER 7, 2007: ownership 75% or more → General partner, trustee or manager
Sep 15, 2020 filing
  • No longer listedLAY, GRACE, VIVIAN · TRUSTEE OF THE LIN-LAY FAMILY 2007 TRUST DATED SEPTEMBER 7, 2007 · Less than 5% · control person · listed since Aug 2018
  • No longer listedYU, MANFRED, HSIAO-WEI · MANAGER, MANAGING DIRECTOR, CCO, COO, TRUSTEE OF THE LIN-LAY FAMILY 2007 TRUST DATED SEPTEMBER 7, 2007 · Less than 5% · control person · listed since Jul 2014
  • AddedSMITH, SCOTT, RANDALL · CHIEF OPERATING OFFICER, CHIEF COMPLIANCE OFFICER · Less than 5% · control person
  • ChangedDALAL, ANUPAM, AKSHAY · title CHIEF INVESTMENT OFFICER → MANAGING MEMBER, CHIEF INVESTMENT OFFICER; ownership Less than 5% → 75% or more
  • ChangedTHE LIN-LAY FAMILY 2007 TRUST DATED SEPTEMBER 7, 2007 · title OWNER → MEMBER; ownership 75% or more → 10–25%; no longer a control person
Mar 28, 2019 filing
  • AddedLAY, GRACE, VIVIAN · TRUSTEE OF THE LIN-LAY FAMILY 2007 TRUST DATED SEPTEMBER 7, 2007 · Less than 5% · control person
  • ChangedDALAL, ANUPAM, AKSHAY · now a control person
  • ChangedLAY, GRACE, VIVIAN · indirect via THE LIN-LAY FAMILY 2007 TRUST DATED SEPTEMBER 7, 2007: title TRUSTEE → BENEFICIARY/TRUSTEE; ownership General partner, trustee or manager → 75% or more
  • ChangedYU, MANFRED, HSIAO-WEI · title MANAGER, MANAGING DIRECTOR, CHIEF COMPLIANCE OFFICER AND CHIEF OPERATING OFFICER → MANAGER, MANAGING DIRECTOR, CCO, COO, TRUSTEE OF THE LIN-LAY FAMILY 2007 TRUST DATED SEPTEMBER 7, 2007
Sep 5, 2018 filing
  • No longer listedLIN, RICHARD, YU-TSANG · MANAGING MEMBER · 75% or more · control person · listed since Jul 2011
  • AddedLAY, GRACE, VIVIAN · TRUSTEE · General partner, trustee or manager · indirect via THE LIN-LAY FAMILY 2007 TRUST DATED SEPTEMBER 7, 2007 · control person
  • AddedTHE LIN-LAY FAMILY 2007 TRUST DATED SEPTEMBER 7, 2007 · OWNER · 75% or more · control person
  • AddedYU, MANFRED, HSIAO-WEI · TRUSTEE · General partner, trustee or manager · indirect via THE LIN-LAY FAMILY 2007 TRUST DATED SEPTEMBER 7, 2007 · control person
  • ChangedYU, MANFRED, HSIAO-WEI · title CHIEF COMPLIANCE OFFICER AND CHIEF OPERATING OFFICER → MANAGER, MANAGING DIRECTOR, CHIEF COMPLIANCE OFFICER AND CHIEF OPERATING OFFICER
Mar 29, 2018 filing
  • AddedDALAL, ANUPAM, AKSHAY · CHIEF INVESTMENT OFFICER · Less than 5%
  • ChangedLIN, RICHARD, YU-TSANG · title MANAGING MEMBER AND CHIEF INVESTMENT OFFICER → MANAGING MEMBER
Mar 29, 2016 filing
  • ChangedLIN, RICHARD, YU-TSANG · title MANAGING MEMBER → MANAGING MEMBER AND CHIEF INVESTMENT OFFICER
Apr 1, 2015 filing (earliest on record)
  • ListedLIN, RICHARD, YU-TSANG · MANAGING MEMBER · 75% or more · control person
  • ListedYU, MANFRED, HSIAO-WEI · CHIEF COMPLIANCE OFFICER AND CHIEF OPERATING OFFICER · Less than 5% · control person

Quarter-over-quarter changes

Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.

ACUTA CAPITAL PARTNERS, LLC Holdings (2026-06-30)

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 PRAXIS PRECISION MEDICINES I PRAX 74006W207 $27.7M 19.32% 82,796 SH
2 WHITEHAWK THERAPEUTICS INC WHWK 00032Q104 $21.5M 14.96% 4,685,912 SH
3 TANGO THERAPEUTICS INC TNGX 87583X109 $12.2M 8.52% 390,949 SH
4 SUTRO BIOPHARMA INC STRO 869367201 $9.0M 6.25% 270,251 SH
5 ARRIVENT BIOPHARMA INC AVBP 04272N102 $7.6M 5.29% 218,694 SH
6 4D MOLECULAR THERAPEUTICS INC FDMT 35104E100 $6.8M 4.71% 507,801 SH
7 BRIGHT MINDS BIOSCIENCES INC DRUG 10919W405 $6.5M 4.54% 92,745 SH
8 OCULAR THERAPEUTIX INC OCUL 67576A100 $5.2M 3.64% 532,481 SH
9 ERASCA INC ERAS 29479A108 $4.9M 3.39% 265,199 SH
10 SURROZEN INC SRZN 86889P208 $4.5M 3.14% 173,395 SH
11 ARGEN SE - ADR ARGX 04016X101 $4.4M 3.04% 4,705 SH
12 MOONLAKE IMMUNOTHERAPEUTICS MLTX 61559X104 $4.2M 2.93% 215,652 SH
13 DESIGN THERAPEUTICS INC DSGN 25056L103 $4.1M 2.85% 282,564 SH
14 MINERVA NEUROSCIENCES NERV 603380205 $3.9M 2.74% 709,500 SH
15 TAYSHA GENE THERAPIES INC TSHA 877619106 $3.8M 2.67% 561,808 SH
16 AVALYN PHARMA INC AVLN 05348Y105 $3.8M 2.64% 115,000 SH
17 AVALO THERAPEUTICS INC AVTX 05338F306 $3.4M 2.40% 186,308 SH
18 AMYLYX PHARMACEUTICALS INC AMLX 03237H101 $3.0M 2.10% 168,115 SH
19 ARTIVA BIOTHERAPEUTICS INC ARTV 04317A107 $2.5M 1.76% 260,416 SH
20 COMPASS THERAPEUTICS INC CMPX 20454B104 $1.3M 0.91% 595,213 SH
21 UNITED THERAPEUTICS CORP UTHR 91307C102 $1.2M 0.84% 2,224 SH
22 CONTINEUM THERAPEUTICS INC-A CTNM 21217B100 $1.0M 0.72% 63,095 SH
23 LB PHARMACEUTICALS INC LBRX 50180M108 $938.6K 0.65% 28,919 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-14 $143.5M 23 0001104659-26-096822
2026-03-31 2026-05-15 $141.8M 27 0001104659-26-062163
2025-12-31 2026-02-17 $147.3M 30 0001104659-26-016119
2025-09-30 2025-11-14 $96.8M 28 0001104659-25-112378
Filer Information
Address
255 SHORELINE DRIVE
SUITE 515
REDWOOD CITY, CA 94065
Phone
(650) 486-0581
Filing Manager
ACUTA CAPITAL PARTNERS, LLC
REDWOOD CITY, CA
Signatory
Scott Smith
Chief Operating Officer